Summary
Summary

Duplication o f the gene fo r the peripheral myelin protein 22 observed an intense LNGF-R immunoreactivity in all layers (PMP22) is the most common cause for
Introduction
Hereditary demyelinating neuropathies are a genetically 1996). Thus, duplication of the PMP22 gene is by far the heterogeneous group o f diseases, the majority of which are most common cause of CMT1 neuropathy. caused either by duplication or deletion of the gene for
Since there is strong evidence that the PMP22 gene is not PMP22 or by point mutations in the genes PMP22, myelin disrupted within the tandem DNA duplication (Killian and protein P() or Connexin 32 (Patel and Lupski, 1994; Harding, Kloepfer, 1979; Chance et al, 1992; Lupski et a l, 1992;  . According to two series, (Hanemann et al., 1994 (Hanemann et al., , 1995 Yoshikawa et al., 1994 (Spreyer et al., A whole sural nerve biopsy was performed and prepared 1991; Lemke, 1993; Zoidl et al., 1995) . Based on this for light and electron microscopic examination, using findings, we hypothesized (Hanemann et al., 1994) that standard techniques (Gabreëls-Festen et al., 1992) . Electron elevated expression of PMP22 at the beginning of the disease microscopic photographs (X2200) covering ~10% of the alters Schwann cell differentiation and leads to a pathological total transverse fascicular area were used for morphometric phenotype.
analysis. The density and diameter distribution of myelinated Thus in this study, our investigations were designed to test fibres were determined using a Zeiss TGZ 3 particle size whether the duplication of PMP22 in CMT1A patients is analyser. On the same prints, the external and axonal associated with an alteration of the Schwann cell phenotype diameters were measured and the g ratio (axon diameter to during the course of the disease as compared with normal fibre diameter) was determined. 'Myelinated axons' were controls.
those presumed to belong to the myelinated fibre group, Various antibodies, such as those directed to the LNGFnamely axons with myelin and those of larger diameters R, S I00 protein, GFAP and myelin proteins, have been used (> 1 .7 jam) without myelin but surrounded by one or more in the past to characterize different Schwann cell phenotypes extra Schwann cell processes. The density of demyelinated (Jessen and Mirsky, 1991; Fan and Gelman, 1992 , 1992) . Low affinity nerve growth factor receptor is of the myelinated fibres per case. The number of onion bulbs expressed during proliferation of foetal Schwann cells but is was scored in randomly chosen areas comprising a total of downregulated when myelination is initiated (at ~18 weeks myelinated of foetal age) (Heumann et al., 1987; Yasuda et al., 1987;  extra Schwann cell processes were considered 'onion bulbs' . DiStefano and Johnson, 1988; Scarpini et al., 1988) . In normal human nerves LNGF-R is barely detectable (Sobue et al., 1988) , but it is re-expressed when axon-Schwann cell
I m m u n o h is to c h e m is tr y
contact is lost during Wallerian degeneration or in acute but Nerves were fixed in 4% paraformaldehyde, embedded in not chronic demyelination in rats and humans (Taniuchi et al., 1986; Heumann et al., 1987; Fan and Gelman, 1992 ; Toews paraffin and cut into 5-10 jim thick serial sections. For immunohistochemical staining the following primary et al, Stoll et al., 1993) . A similar regulation has been antibodies were used (dilution in parenthesis): mouse shown for GFAP expression in rats (Jessen et al., 1984, monoclonal anti-human LNGF-R (1:100); mouse monoclonal 1990; Toews et al, 1992) .
anti-GFAP (1:10); mouse monoclonal anti-myelin In this study we show expression of LNGF-R in Schwann protein (MBP) (1:500); mouse monoclonal PCNA (1:200) cells of CMT1A nerve biopsies at early disease stages as (all Boehringer Mannheim, Penzberg, Germany); rabbit well as changes of LNGF-R staining during onion bulb monoclonal anti-S 100 (1:200; Camon, Wiesbaden, Germany), formation. These LNGF-R-positive Schwann cells were GFAP As secondary antibodies biotinylated anti-rabbit resp. rat negative indicating an unique Schwann cell phenotype in absorbed anti-mouse IgG (Vector, Burlingame, Calif., USA) CMT1A neuropathy that might result from the genetic defect. diluted 1:50 were used. Staining was performed with the avidin-biotin-peroxidase complex method using Vectastain A B C kit (Vector) according to the manufacturer's protocol.
/
Material and methods
N erve sp ecim en s
of the sural nerve were taken from
Results
We have 13 CMT1A patients diagnosed to suffer from CMT1A by clinical, biopsies. For 11 patients morphometric data are presented in electrophysiological and pathological criteria according to Table 1 . Morphometric results are ordered according to the guidelines of the European consortium to study hereditary increase in percentage of onion bulbs and decrease in density motor sensory neuropathy (De Visser et al., 1993) prior to of myelinated fibres. No such morphometric analysis was the availability of genetic testing after informed consent.
available for the two patients (Cases 12 and 13) with most Years later diagnosis of CMT1A neuropathy was genetically proven by testing for PMP22 duplication as previously advanced onion bulb formation, but routine histology on paraffin sections showed very large onion bulbs, and described (Hoogendijk et al., 1992) . Normal nerves were immunohistochemistry with M BP antibody revealed taken either from multiorgan donors without neuropathy after severe loss o f myelinated nerve fibres. Paraffin sections of informed consent or from patients biopsied for diagnostic sural nerve biopsies from patients in different age groups years, n = 11); 10530 (11-20 years, n = 5); 9640 (21-30 years, n = 7). '''Mean of (6-10 years, n = 2), 0.67 (11-20 years, n ~ 3); 0.66 (21-50 years, n = 3).
an of age-related controls: 14170 (2-5 years, n -6); 13180 (6-10 controls: 0.73 (2-5 years, n = 2); 0.67
(patient age at biopsy: 5 years, n = 2; 15 years, n = 2) showed with an antibody to GFAP showed no GFAP staining (Fig. no abnormalities at routine morphological examination and 1H), which is in contrast to findings in acute demyelination, endoneurial cells were only rarely LNGF-R or GFAP positive, where GFAP and LNGF-R are upregulated concomitantly as previously described (Sobue et a l., 1988 ) (results not shown). (Toews et al., 1992) .
When onion bulb formation and myelin fibre loss were Immunostaining of sural nerves from patients with more advanced (Fig. 2A , E and G; Case 10 in Table I ) LNGFgenetically proven C M T IA neuropathy showed a massive R staining was increased and was clearly seen associated increase in LNGF-R expression that varied depending on the with the onion bulbs (Fig. 2C) ; LNGF-R staining could be stage of myelin loss and onion bulb formation, The early demonstrated in all lamellae of the onion bulbs including stage of the disease was characterized by very few small onion bulbs (Ouvrier et al., 1987; Gabreëls-Festen et al., adjacent to sheaths (Fig.  and E) . Incubation of these nerves with an against 1992), a moderate decrease in density of myelinated fibres and revealed a staining pattern very different to that of the LNGFmostly normal myelin sheaths as revealed by morphometric R. Glial fibrillary acidic protein staining was increased as analysis (see Fig. IA and Case 1 in Table 1 ). In this group compared with controls but onion bulbs were GFAP negative of patients, enhanced LNGF-R staining as compared with age-matched controls was observed ( Fig. 1C and E At most advanced stages ol , we 1). The crescent-shaped staining adjacent to no longer detect LNGF-R immunoreactivity (Fig. 2D ) in contour with LNGF-R antibody in transverse sections (Fig. accordance with a previous report (Sobue et al., . In IE ) and along nerve longitudinal sections ( Fig. ID and F) forming Schwann that in to nating contrast to earlier disease stages, onion bulbs had larger in diameter (Fig. 2B ) as revealed by labelling aim mai •es still co nt Schwann cells express LNGF-R (Fig. 1D-F) . To analyse small MBP-positive myelin sheaths (arrows in Fig. 2F ). whether the increased expression of LNGF-R in C M T IA onion of nerve patients is related to enhanced Schwann cell proliferation, arrows in Fig. 2F ). PCNA staining revealed no proliferating sections were stained with monoclonal antibody to proliferation marker PCNA (Connolly et al., 1993) . was no Staining of non-CMT onion bulbs in nerve bi cells were PCNA positive (Fig. 1G) . There was no PCNA CIDP patients showed no LNGF-R staining (Fig. 3D) as immunoreaction in the endoneurium in any of the control perviously described (Sobue et al., 1988) . Few onion bulbs nerves from the different age groups examined. Further showed scarcely unmyelinated fibres in the outer layer as characterization of Schwann cells at the early disease stages could be shown by ultrastructural analysis (Fig. 3A and B) . 
Discussion
In this study, we used different immunohistochemical markers to characterize Schwann cell phenotypes at various disease stages of C M T IA neuropathy as compared with agematched normal controls. The principal finding of this study is that Schwann cells transiently and pathologically express LNGF-R in C M T IA neuropathy. Schwann cells are the only endoneurial cells that are capable of expressing LNGF-R in peripheral nerves (Taniuchi w reus in onion were far too lew to explain staining of all lamellae in each onion bulb. Furthermore, morphometric analysis revealed evidence for demyelination in our series. In early disease elination (Table I ) .it later disease stages, where LNGF-R staining could in all layers of onion be Fig. 2E ) virtually no signs of demyelination e s (Case 10, Table I that Schwann cells in all layers of the onion bulbs including those adjacent to the myelin sheath were LNGF-R positive. Again this is unusual, since nerve biopsies of CIDP patients with a similar content of onion bulb formation and thinly demyelination is pronounced at the early stages, and onion myelinated nerve fibres were always LNGF-R negative (Fig. bulbs, as a result of Schwann cell proliferation, gradually 3D) (Sobue et ah, 1988) . Ultrastructural analysis showed appear later during the lirst decade of the disease (GabreiHsfew unmyelintated axons in the outer lamellae of some of Festen et al. i ). In addition, endoneurial the onion bulbs ( Fig. 3A and B) . Since they were only found contribute to the pool of PCNA-positive proliferating cells, in few onion bulbs and were restricted to the outer lamellae, To further characterize the Schwann cells in C M T IA , we •.. pr lê:
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,.. In conclusion, we describe an unique Schwann cell enotype in CMT1A neuropathy that has not been reported of S 100 before. Early in the course of the disease with mostly normal expression. We found SICK) labelling of all Schwann cells in myelin sheaths, Schwann cells express LNGF-R and S100 all t 'MTl A biopsies (data not shown). Glial fibrillary acidic but lack GFAP and PCNA staining. In more advanced disease imnumostaining could only be detected in disease stages we found LNGF-R-positive, SI 00-positive and PCNAongoing onion bulb formation and showed a positive Schwann cells in the inner as well as outer lamellae pattern ol localization that is of the onion bulbs, which were still GFAP-negative. Table 1 ).
Some onion bulbs lack a central myelinated fibre (arrow). C, E, G and H are corresponding paraffin sections stained for LNGF-R {C and K}. GFAP (G> and PCNA (H) . Note that Schwann cells in onion bulbs strongly express LNGF-R (arrows in C, and larger 
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The unusual LNGF-R expression by Schwann cells in CMT1A neuropathy could either be a primary effect due to PMP22 gene duplication and the growth regulatory functions Fan X, Gelman BB. Schwann cell nerve growth factor receptor expression during initiation of remyelination. J Neurosci Res 1992; 31: 58-67. o f PM P22 in the .cell cycle, or a secondary effect caused by Fischbeck KH. Charcot-Marie-Tooth disease type 1A, 9 November the disease process. It is an intriguing question whether or 1 9 9 2 , S a n F r a n c i s c o , CA, USA. Neuromuscul Disord 1993;3:81-2.
not Schwann cells pathologically remain LNGF-R positive in foetal development after commencement of myelination in CMT1A neuropathy, an issue that obviously cannot be addressed experimentally. Nevertheless, the present findings support our earlier hypothesis that PMP22 gene duplication and overexpression may directly or secondarily alter the Schwann cell phenotype early in the course of the disease. At present, the functional consequences of aberrant LNGF-R expression of Schwann cells in CMT1A neuropathy is
